Topics

Catalent begins production of Zumutor's lead candidate

07:36 EST 14 Feb 2020 | SmartBrief

Catalent Biologics has started manufacturing Zumutor Biologics' lead candidate, ZM008, a treatment that targets solid tumors. -More

Original Article: Catalent begins production of Zumutor's lead candidate

NEXT ARTICLE

More From BioPortfolio on "Catalent begins production of Zumutor's lead candidate"

Quick Search

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...